Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy. | |
Yeying Liu; Yuan Huang; Jie Ding; Nannan Liu; Shuang Peng; Jiangang Wang; Feng Wang; Yingjie Zhang | |
刊名 | Cancer cell international |
2019 | |
卷号 | Vol.19页码:124 |
关键词 | AKT Bcl-xL Colon cancer GSK-3β SC66 |
ISSN号 | 1475-2867 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4735568 |
专题 | 湖南大学 |
作者单位 | Department of Health Management, The Third Xiangya Hospital, Central South University, College of Biology, Hunan University, No. 1, Denggao Road, Changsha, China. 3Department of Emergency Surgery, The Second Military Medical University, Shanghai, China. 2Department of Gastroenterology, The Tenth People's Hospital of Shanghai, Tongji University, Shanghai, China. 4Shenzhen Institute, Hunan University, Shenzhen, China. |
推荐引用方式 GB/T 7714 | Yeying Liu,Yuan Huang,Jie Ding,et al. Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy.[J]. Cancer cell international,2019,Vol.19:124. |
APA | Yeying Liu.,Yuan Huang.,Jie Ding.,Nannan Liu.,Shuang Peng.,...&Yingjie Zhang.(2019).Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy..Cancer cell international,Vol.19,124. |
MLA | Yeying Liu,et al."Targeting Akt by SC66 triggers GSK-3β mediated apoptosis in colon cancer therapy.".Cancer cell international Vol.19(2019):124. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论